FAU Brain Institute Awarded $780,000 From Stiles-Nicholson Foundation To Launch ASCEND Program

Posted by on Feb 23, 2018 in Newsroom | 0 comments

BOCA RATON, FL. –  To address the national shortage in STEM (science-technology-engineering and math) career-oriented students, the Florida Atlantic UniversityBrain Institute has received a $780,000 grant from the Stiles-Nicholson Foundation to launch an innovative program targeted at middle and high school students in Palm Beach County. ASCEND (Advancing STEM: Community Engagement through Neuroscience Discovery) will tap the energy and intellect of undergraduate, graduate and post-doctoral neuroscience trainees associated with FAU Brain Institute labs, the Harriet L....

Read More

Liquidia raises $25.5 million in new capital, wants even more

Posted by on Feb 21, 2018 in Newsroom | 0 comments

MORRISVILLE, N.C. –  Liquidia Technologies Inc. has raised $25.5 million in equity, according to a Tuesday filing with the Securities and Exchange Commission. The company is still seeking to raise $27.8 million to meet its goal of $53.3 million. The money was raised by seven investors. Kevin Gordon, a former senior executive at QuintilesIMS, recently joined Liquidia as its president and chief financial officer. Liquidia Technologies is a nanotechnology company that designs, develops and manufactures precisely engineered particles and films for various life and material science...

Read More

AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization’s Board of Directors

Posted by on Feb 16, 2018 in Newsroom, SEBIO News | 0 comments

GAINESVILLE, FL. and BOSTON, MA. – Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced the election of Sue Washer, President and Chief Executive Officer, to the Biotechnology Innovation Organization (BIO)’s Board of Directors. “For more than two decades, BIO has been a champion of the rapidly expanding biotechnology industry and I am honored to be elected to the organization’s Board of Directors,”...

Read More

Friday deadline for first RTP MedTech Pitch event

Posted by on Feb 15, 2018 in Newsroom | 0 comments

If you’re building a company in the “3-D” world of Devices, Diagnostics or Digital health products, you have until the end of the day this Friday, Feb. 16, to seek fame and fortune. The North Carolina Biotechnology Center has partnered with MedTech Innovator, the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies, to host the inaugural Southeast Region Pitch Event for MedTech’s annual $500,000 competition. The event will be held at NCBiotech on April 9. And because NCBiotech is partnering with MedTech to sponsor...

Read More

Five new tenants added at VA Bio+Tech Park in downtown Richmond

Posted by on Feb 15, 2018 in Newsroom | 0 comments

RICHMOND, VA. – VA Bio+Tech Park, formerly called the Virginia Biotechnology Research Park in downtown Richmond, has five new tenants, including a firm developing a gel patch for repairing perforated eardrums and a company developing renewable chemicals used to make everyday products. Officials on Wednesday announced the new tenants to the 34-acre research and technology park located near Virginia Commonwealth University’s medical campus. “The addition of these new companies to the park further strengthens the Richmond region’s innovation and entrepreneurial ecosystem,”...

Read More

Vaxart, Inc. Closes Merger with Aviragen Therapeutics, Inc.

Posted by on Feb 14, 2018 in Newsroom | 0 comments

ATLANTA, GA. and SOUTH SAN FRANCISCO, CA. – Vaxart, Inc. (NASDAQ: VXRT) today announced the completion of its merger with Aviragen Therapeutics, Inc. In connection with the merger, Aviragen Therapeutics, Inc. changed its name to Vaxart, Inc. and effected a 1-for-11 reverse split of its common stock. The combined company will commence trading on a post-reverse split basis effective at the opening of the market on February 14, 2018 on Nasdaq under the symbol “VXRT.” “We are very pleased to complete this merger, which marks a significant milestone for Vaxart,” said Wouter Latour,...

Read More